Site Members can sign up for company wide alerts
Lawsuit Overview
November 18, 2013 (Shareholders Foundation) - An investor, who currently hold shares of shares of Santarus, Inc. (NASDAQ:SNTS) filed a lawsuit in effort to halt the proposed takeover of Santarus, Inc. by Salix Pharmaceuticals, Ltd for $32.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:SNTS stockholders arising out of the attempt...
You must register (for free) or login to view the entire case.